Consumer Groups, AAI Push Pay-For-Delay Ban
The American Antitrust Institute, together with a coalition of consumer groups, is urging lawmakers to include a ban on pay-for-delay pharmaceutical patent settlements in the final version of health care reform...To view the full article, register now.
Already a subscriber? Click here to view full article